News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News TCT 2014 Views Differ on Future of Percutaneous Mitral Valve Therapies September 16, 2014
News Conference News TCT 2014 New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR September 15, 2014
News Conference News TCT 2014 TCT Course Director Outlines Current TAVR Controversies September 14, 2014
News Conference News TCT 2014 Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk September 13, 2014
News Conference News ESC 2014 Mitral Regurgitation Associated with Decreased Survival in TAVR Patients Yael L. Maxwell September 03, 2014
News Conference News EuroPCR 2014 Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement Caitlin E. Cox May 23, 2014
News Conference News EuroPCR 2014 New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke L.A. McKeown May 23, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted Yael L. Maxwell March 30, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News TCT 2013 Second-Generation TAVR Device Overcomes Issues of Current Valves October 31, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News AATS 2013 Promising Early Valve-in-Valve Results Seen in Small Nordic Registry L.A. McKeown May 07, 2013
News Conference News ACC 2013 ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting L.A. McKeown March 14, 2013
News Conference News ACC 2013 PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device L.A. McKeown March 09, 2013